Security Snapshot

NATIONAL HEALTH INVESTORS INC - COM (NHI) Institutional Ownership

CUSIP: 63633D104

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

292

Shares (Excl. Options)

34,406,977

Price

$76.37

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / COM
Symbol
NHI on NYSE
Price per share
$80.86
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
34,406,977
Total reported value
$2,630,254,296
% of total 13F portfolios
0%
Share change
-277,148
Value change
-$22,263,571
Number of holders
292
Price from insider filings
$80.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • NHI - NATIONAL HEALTH INVESTORS INC - COM is tracked under CUSIP 63633D104.
  • 292 institutions reported positions in Q4 2025.
  • Schedule 13D/13G significant owner rows are not currently available.

What Changed

  • Holder count moved from 292 to 31 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,630,254,296 to $19,131,448.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 292 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 63633D104?
CUSIP 63633D104 identifies NHI - NATIONAL HEALTH INVESTORS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

As of 31 Dec 2025, 292 institutional investors reported holding 34,406,977 shares of NATIONAL HEALTH INVESTORS INC - COM (NHI).

Institutional Holders of NATIONAL HEALTH INVESTORS INC - COM (NHI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 236,335 $19,131,448 +$8,232,005 $80.86 31
2025 Q4 34,406,977 $2,630,254,296 -$22,263,571 $76.37 292
2025 Q3 33,722,892 $2,681,026,737 -$58,995,633 $79.50 280
2025 Q2 34,618,618 $2,429,765,734 +$248,763,683 $70.12 271
2025 Q1 31,076,974 $2,297,128,154 +$7,977,696 $73.86 281
2024 Q4 30,923,026 $2,144,520,370 +$56,777,254 $69.30 275
2024 Q3 30,022,755 $2,524,018,356 +$214,371,978 $84.06 278
2024 Q2 27,458,920 $1,861,437,635 +$19,257,111 $67.73 229
2024 Q1 26,817,544 $1,686,322,928 -$13,428,622 $62.83 220
2023 Q4 27,117,098 $1,516,336,344 +$13,317,281 $55.85 209
2023 Q3 26,906,387 $1,383,584,537 -$33,062,776 $51.36 208
2023 Q2 27,553,998 $1,446,095,650 +$393,489 $52.42 208
2023 Q1 27,543,935 $1,422,308,676 +$31,346,033 $51.58 226
2022 Q4 26,909,523 $1,407,423,944 -$44,045,271 $52.22 232
2022 Q3 27,597,325 $1,561,504,304 -$124,229,662 $56.53 237
2022 Q2 29,527,130 $1,791,589,806 -$40,325,691 $60.61 231
2022 Q1 30,316,025 $1,789,810,375 +$59,579,461 $59.01 230
2021 Q4 29,317,972 $1,686,100,497 +$18,226,569 $57.47 223
2021 Q3 28,998,265 $1,553,711,069 -$50,781,770 $53.50 230
2021 Q2 29,912,962 $2,007,211,493 -$8,367,225 $67.05 235
2021 Q1 29,776,606 $2,154,175,157 -$14,470,987 $72.28 245
2020 Q4 29,651,276 $2,052,686,196 -$938,900 $69.17 239
2020 Q3 30,063,506 $1,813,246,475 -$78,704,840 $60.27 225
2020 Q2 31,346,509 $1,903,970,672 +$15,958,456 $60.72 232
2020 Q1 31,353,485 $1,554,116,212 -$40,529,352 $49.52 233
2019 Q4 31,568,081 $2,573,176,273 -$2,115,308 $81.48 266
2019 Q3 31,539,359 $2,599,634,285 +$63,896,471 $82.39 238
2019 Q2 30,744,385 $2,399,859,161 +$34,008,639 $78.03 236
2019 Q1 30,562,269 $2,401,807,541 +$17,788,323 $78.55 242
2018 Q4 30,336,975 $2,292,865,896 +$49,529,460 $75.54 232
2018 Q3 29,596,346 $2,237,016,803 +$20,791,880 $75.59 227
2018 Q2 29,348,152 $2,162,440,261 -$5,363,286 $73.68 236
2018 Q1 29,441,995 $1,980,979,580 -$16,455,218 $67.29 225
2017 Q4 29,839,442 $2,249,336,250 +$8,253,997 $75.38 214
2017 Q3 29,539,406 $2,283,994,869 +$27,610,442 $77.29 206
2017 Q2 29,175,233 $2,310,553,403 +$63,990,154 $79.20 192
2017 Q1 28,446,378 $2,066,009,894 +$282,301,603 $72.63 205
2016 Q4 27,570,552 $2,044,671,159 +$17,248,603 $74.17 202
2016 Q3 28,510,276 $2,236,263,546 +$127,999,854 $78.48 209
2016 Q2 26,772,007 $2,010,273,821 +$125,024,842 $75.09 198
2016 Q1 25,460,168 $1,693,715,192 -$4,971,795 $66.52 200
2015 Q4 25,651,691 $1,561,654,067 +$91,965,489 $60.87 191
2015 Q3 24,539,083 $1,408,613,415 -$35,148,352 $57.49 180
2015 Q2 25,107,854 $1,564,220,648 +$22,119,112 $62.30 180
2015 Q1 24,735,981 $1,756,942,619 +$24,069,505 $71.01 178
2014 Q4 24,424,512 $1,709,151,912 +$366,891,862 $69.96 182
2014 Q3 19,210,075 $1,097,811,614 +$1,154,893 $57.14 168
2014 Q2 19,185,914 $1,199,561,333 -$7,917,572 $62.56 168
2014 Q1 19,324,505 $1,168,282,299 +$86,510,607 $60.46 163